English
简体中文
Total: £ 56.28
Published Date: 2025-08-08 | Pages: 86 | Tables: 86 | Medical Care
The global market for Haemostasis Diagnostics was valued at US$ 3121 million in the year 2024 and is projected to reach a revised size of US$ 5449 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Haemostasis diagnostics refers to the clinical assessment of the body's ability to maintain blood fluidity under normal conditions and to initiate clotting when necessary to prevent excessive bleeding. It involves laboratory testing of the three main components of the haemostatic system: vascular integrity, platelet function, and plasma coagulation factors. Typical tests include Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Thrombin Time (TT), Fibrinogen level, D-dimer, and platelet aggregation studies. Haemostasis diagnostics plays a critical role in diagnosing bleeding disorders, thrombotic diseases, and in monitoring surgical risk and anticoagulant therapy.
Haemostasis diagnostics is a vital component of modern laboratory medicine, supporting timely diagnosis and clinical decision-making in both acute and chronic care settings. It is widely applied across multiple specialties, including hematology, cardiology, surgery, emergency medicine, and critical care. As the complexity of patient conditions increases—especially with the rise of aging populations and chronic comorbidities—the demand for accurate, real-time haemostatic evaluation continues to grow. In many hospitals, automated haemostasis analyzers capable of performing high-throughput testing with minimal manual intervention have become standard. These systems not only offer efficiency but also improve test reproducibility and integration with digital health platforms.
In the Chinese medical system, haemostasis diagnostics is increasingly emphasized in both inpatient and outpatient settings. With the rise of cardiovascular interventions, orthopedic surgeries, oncology treatments, and liver disease management, the need for comprehensive haemostasis assessment has expanded. In addition to basic clotting tests, there is growing interest in advanced assays like thromboelastography (TEG), platelet function testing, and anti-Xa assays for direct oral anticoagulant monitoring. Domestic diagnostic manufacturers are also investing in the development of localized instruments and reagents to reduce costs and improve accessibility, especially in county and township-level hospitals. As precision medicine and perioperative risk management evolve, haemostasis diagnostics is expected to become more predictive and patient-specific.
This report aims to provide a comprehensive presentation of the global market for Haemostasis Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemostasis Diagnostics.
The Haemostasis Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Haemostasis Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Haemostasis Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sysmex
Stago
Werfen
Sekisui Medical
Behnk Elektronik (BE)
Roche
Thermo Fischer
Beijing Succeeder Technology
Mindray Medical
Shanghai Sun Biotechnology
Rayto Life and Analytical Sciences
Beijing ZONCI Technology Development
Shenzhen Dymind Biotechnology
TECO
ACCURDX
Segment by Type
Diagnostic Equipment
Diagnostic Reagents
Segment by Application
Hospital
Research Institutions
Diagnostic Centers
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Haemostasis Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Haemostasis Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Equipment
1.2.3 Diagnostic Reagents
1.3 Market by Application
1.3.1 Global Haemostasis Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Diagnostic Centers
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Haemostasis Diagnostics Market Perspective (2020-2031)
2.2 Global Haemostasis Diagnostics Growth Trends by Region
2.2.1 Global Haemostasis Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Haemostasis Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Haemostasis Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Haemostasis Diagnostics Market Dynamics
2.3.1 Haemostasis Diagnostics Industry Trends
2.3.2 Haemostasis Diagnostics Market Drivers
2.3.3 Haemostasis Diagnostics Market Challenges
2.3.4 Haemostasis Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Haemostasis Diagnostics Players by Revenue
3.1.1 Global Top Haemostasis Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Haemostasis Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Top Haemostasis Diagnostics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Haemostasis Diagnostics Revenue
3.4 Global Haemostasis Diagnostics Market Concentration Ratio
3.4.1 Global Haemostasis Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Haemostasis Diagnostics Revenue in 2024
3.5 Global Key Players of Haemostasis Diagnostics Head office and Area Served
3.6 Global Key Players of Haemostasis Diagnostics, Product and Application
3.7 Global Key Players of Haemostasis Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Haemostasis Diagnostics Breakdown Data by Type
4.1 Global Haemostasis Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Haemostasis Diagnostics Forecasted Market Size by Type (2026-2031)
5 Haemostasis Diagnostics Breakdown Data by Application
5.1 Global Haemostasis Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Haemostasis Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Haemostasis Diagnostics Market Size (2020-2031)
6.2 North America Haemostasis Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Haemostasis Diagnostics Market Size by Country (2020-2025)
6.4 North America Haemostasis Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Haemostasis Diagnostics Market Size (2020-2031)
7.2 Europe Haemostasis Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Haemostasis Diagnostics Market Size by Country (2020-2025)
7.4 Europe Haemostasis Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Haemostasis Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Haemostasis Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Haemostasis Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Haemostasis Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Haemostasis Diagnostics Market Size (2020-2031)
9.2 Latin America Haemostasis Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Haemostasis Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Haemostasis Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Haemostasis Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Haemostasis Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Haemostasis Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Haemostasis Diagnostics Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sysmex
11.1.1 Sysmex Company Details
11.1.2 Sysmex Business Overview
11.1.3 Sysmex Haemostasis Diagnostics Introduction
11.1.4 Sysmex Revenue in Haemostasis Diagnostics Business (2020-2025)
11.1.5 Sysmex Recent Development
11.2 Stago
11.2.1 Stago Company Details
11.2.2 Stago Business Overview
11.2.3 Stago Haemostasis Diagnostics Introduction
11.2.4 Stago Revenue in Haemostasis Diagnostics Business (2020-2025)
11.2.5 Stago Recent Development
11.3 Werfen
11.3.1 Werfen Company Details
11.3.2 Werfen Business Overview
11.3.3 Werfen Haemostasis Diagnostics Introduction
11.3.4 Werfen Revenue in Haemostasis Diagnostics Business (2020-2025)
11.3.5 Werfen Recent Development
11.4 Sekisui Medical
11.4.1 Sekisui Medical Company Details
11.4.2 Sekisui Medical Business Overview
11.4.3 Sekisui Medical Haemostasis Diagnostics Introduction
11.4.4 Sekisui Medical Revenue in Haemostasis Diagnostics Business (2020-2025)
11.4.5 Sekisui Medical Recent Development
11.5 Behnk Elektronik (BE)
11.5.1 Behnk Elektronik (BE) Company Details
11.5.2 Behnk Elektronik (BE) Business Overview
11.5.3 Behnk Elektronik (BE) Haemostasis Diagnostics Introduction
11.5.4 Behnk Elektronik (BE) Revenue in Haemostasis Diagnostics Business (2020-2025)
11.5.5 Behnk Elektronik (BE) Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Haemostasis Diagnostics Introduction
11.6.4 Roche Revenue in Haemostasis Diagnostics Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Thermo Fischer
11.7.1 Thermo Fischer Company Details
11.7.2 Thermo Fischer Business Overview
11.7.3 Thermo Fischer Haemostasis Diagnostics Introduction
11.7.4 Thermo Fischer Revenue in Haemostasis Diagnostics Business (2020-2025)
11.7.5 Thermo Fischer Recent Development
11.8 Beijing Succeeder Technology
11.8.1 Beijing Succeeder Technology Company Details
11.8.2 Beijing Succeeder Technology Business Overview
11.8.3 Beijing Succeeder Technology Haemostasis Diagnostics Introduction
11.8.4 Beijing Succeeder Technology Revenue in Haemostasis Diagnostics Business (2020-2025)
11.8.5 Beijing Succeeder Technology Recent Development
11.9 Mindray Medical
11.9.1 Mindray Medical Company Details
11.9.2 Mindray Medical Business Overview
11.9.3 Mindray Medical Haemostasis Diagnostics Introduction
11.9.4 Mindray Medical Revenue in Haemostasis Diagnostics Business (2020-2025)
11.9.5 Mindray Medical Recent Development
11.10 Shanghai Sun Biotechnology
11.10.1 Shanghai Sun Biotechnology Company Details
11.10.2 Shanghai Sun Biotechnology Business Overview
11.10.3 Shanghai Sun Biotechnology Haemostasis Diagnostics Introduction
11.10.4 Shanghai Sun Biotechnology Revenue in Haemostasis Diagnostics Business (2020-2025)
11.10.5 Shanghai Sun Biotechnology Recent Development
11.11 Rayto Life and Analytical Sciences
11.11.1 Rayto Life and Analytical Sciences Company Details
11.11.2 Rayto Life and Analytical Sciences Business Overview
11.11.3 Rayto Life and Analytical Sciences Haemostasis Diagnostics Introduction
11.11.4 Rayto Life and Analytical Sciences Revenue in Haemostasis Diagnostics Business (2020-2025)
11.11.5 Rayto Life and Analytical Sciences Recent Development
11.12 Beijing ZONCI Technology Development
11.12.1 Beijing ZONCI Technology Development Company Details
11.12.2 Beijing ZONCI Technology Development Business Overview
11.12.3 Beijing ZONCI Technology Development Haemostasis Diagnostics Introduction
11.12.4 Beijing ZONCI Technology Development Revenue in Haemostasis Diagnostics Business (2020-2025)
11.12.5 Beijing ZONCI Technology Development Recent Development
11.13 Shenzhen Dymind Biotechnology
11.13.1 Shenzhen Dymind Biotechnology Company Details
11.13.2 Shenzhen Dymind Biotechnology Business Overview
11.13.3 Shenzhen Dymind Biotechnology Haemostasis Diagnostics Introduction
11.13.4 Shenzhen Dymind Biotechnology Revenue in Haemostasis Diagnostics Business (2020-2025)
11.13.5 Shenzhen Dymind Biotechnology Recent Development
11.14 TECO
11.14.1 TECO Company Details
11.14.2 TECO Business Overview
11.14.3 TECO Haemostasis Diagnostics Introduction
11.14.4 TECO Revenue in Haemostasis Diagnostics Business (2020-2025)
11.14.5 TECO Recent Development
11.15 ACCURDX
11.15.1 ACCURDX Company Details
11.15.2 ACCURDX Business Overview
11.15.3 ACCURDX Haemostasis Diagnostics Introduction
11.15.4 ACCURDX Revenue in Haemostasis Diagnostics Business (2020-2025)
11.15.5 ACCURDX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Haemostasis Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostic Equipment
Table 3. Key Players of Diagnostic Reagents
Table 4. Global Haemostasis Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Haemostasis Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Haemostasis Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Haemostasis Diagnostics Market Share by Region (2020-2025)
Table 8. Global Haemostasis Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Haemostasis Diagnostics Market Share by Region (2026-2031)
Table 10. Haemostasis Diagnostics Market Trends
Table 11. Haemostasis Diagnostics Market Drivers
Table 12. Haemostasis Diagnostics Market Challenges
Table 13. Haemostasis Diagnostics Market Restraints
Table 14. Global Haemostasis Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Haemostasis Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Haemostasis Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemostasis Diagnostics as of 2024)
Table 17. Ranking of Global Top Haemostasis Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Haemostasis Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Haemostasis Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Haemostasis Diagnostics, Product and Application
Table 21. Global Key Players of Haemostasis Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Haemostasis Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Haemostasis Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Haemostasis Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Haemostasis Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Haemostasis Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Haemostasis Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Haemostasis Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Haemostasis Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Haemostasis Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Haemostasis Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Haemostasis Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Haemostasis Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Haemostasis Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Haemostasis Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Haemostasis Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Haemostasis Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Haemostasis Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Haemostasis Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Haemostasis Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Haemostasis Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Haemostasis Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Haemostasis Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Haemostasis Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Sysmex Company Details
Table 47. Sysmex Business Overview
Table 48. Sysmex Haemostasis Diagnostics Product
Table 49. Sysmex Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 50. Sysmex Recent Development
Table 51. Stago Company Details
Table 52. Stago Business Overview
Table 53. Stago Haemostasis Diagnostics Product
Table 54. Stago Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Stago Recent Development
Table 56. Werfen Company Details
Table 57. Werfen Business Overview
Table 58. Werfen Haemostasis Diagnostics Product
Table 59. Werfen Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Werfen Recent Development
Table 61. Sekisui Medical Company Details
Table 62. Sekisui Medical Business Overview
Table 63. Sekisui Medical Haemostasis Diagnostics Product
Table 64. Sekisui Medical Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Sekisui Medical Recent Development
Table 66. Behnk Elektronik (BE) Company Details
Table 67. Behnk Elektronik (BE) Business Overview
Table 68. Behnk Elektronik (BE) Haemostasis Diagnostics Product
Table 69. Behnk Elektronik (BE) Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Behnk Elektronik (BE) Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Haemostasis Diagnostics Product
Table 74. Roche Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Thermo Fischer Company Details
Table 77. Thermo Fischer Business Overview
Table 78. Thermo Fischer Haemostasis Diagnostics Product
Table 79. Thermo Fischer Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Thermo Fischer Recent Development
Table 81. Beijing Succeeder Technology Company Details
Table 82. Beijing Succeeder Technology Business Overview
Table 83. Beijing Succeeder Technology Haemostasis Diagnostics Product
Table 84. Beijing Succeeder Technology Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Beijing Succeeder Technology Recent Development
Table 86. Mindray Medical Company Details
Table 87. Mindray Medical Business Overview
Table 88. Mindray Medical Haemostasis Diagnostics Product
Table 89. Mindray Medical Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Mindray Medical Recent Development
Table 91. Shanghai Sun Biotechnology Company Details
Table 92. Shanghai Sun Biotechnology Business Overview
Table 93. Shanghai Sun Biotechnology Haemostasis Diagnostics Product
Table 94. Shanghai Sun Biotechnology Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Shanghai Sun Biotechnology Recent Development
Table 96. Rayto Life and Analytical Sciences Company Details
Table 97. Rayto Life and Analytical Sciences Business Overview
Table 98. Rayto Life and Analytical Sciences Haemostasis Diagnostics Product
Table 99. Rayto Life and Analytical Sciences Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Rayto Life and Analytical Sciences Recent Development
Table 101. Beijing ZONCI Technology Development Company Details
Table 102. Beijing ZONCI Technology Development Business Overview
Table 103. Beijing ZONCI Technology Development Haemostasis Diagnostics Product
Table 104. Beijing ZONCI Technology Development Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Beijing ZONCI Technology Development Recent Development
Table 106. Shenzhen Dymind Biotechnology Company Details
Table 107. Shenzhen Dymind Biotechnology Business Overview
Table 108. Shenzhen Dymind Biotechnology Haemostasis Diagnostics Product
Table 109. Shenzhen Dymind Biotechnology Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 110. Shenzhen Dymind Biotechnology Recent Development
Table 111. TECO Company Details
Table 112. TECO Business Overview
Table 113. TECO Haemostasis Diagnostics Product
Table 114. TECO Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 115. TECO Recent Development
Table 116. ACCURDX Company Details
Table 117. ACCURDX Business Overview
Table 118. ACCURDX Haemostasis Diagnostics Product
Table 119. ACCURDX Revenue in Haemostasis Diagnostics Business (2020-2025) & (US$ Million)
Table 120. ACCURDX Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Haemostasis Diagnostics Picture
Figure 2. Global Haemostasis Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Haemostasis Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Diagnostic Equipment Features
Figure 5. Diagnostic Reagents Features
Figure 6. Global Haemostasis Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Haemostasis Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Other Case Studies
Figure 12. Haemostasis Diagnostics Report Years Considered
Figure 13. Global Haemostasis Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Haemostasis Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Haemostasis Diagnostics Market Share by Region: 2024 VS 2031
Figure 16. Global Haemostasis Diagnostics Market Share by Players in 2024
Figure 17. Global Haemostasis Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Haemostasis Diagnostics Revenue in 2024
Figure 19. North America Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Haemostasis Diagnostics Market Share by Country (2020-2031)
Figure 21. United States Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Haemostasis Diagnostics Market Share by Country (2020-2031)
Figure 25. Germany Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Haemostasis Diagnostics Market Share by Region (2020-2031)
Figure 33. China Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Haemostasis Diagnostics Market Share by Country (2020-2031)
Figure 41. Mexico Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Haemostasis Diagnostics Market Share by Country (2020-2031)
Figure 45. Israel Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Haemostasis Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Sysmex Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 49. Stago Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 50. Werfen Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 51. Sekisui Medical Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 52. Behnk Elektronik (BE) Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 54. Thermo Fischer Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 55. Beijing Succeeder Technology Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 56. Mindray Medical Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 57. Shanghai Sun Biotechnology Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 58. Rayto Life and Analytical Sciences Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 59. Beijing ZONCI Technology Development Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 60. Shenzhen Dymind Biotechnology Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 61. TECO Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 62. ACCURDX Revenue Growth Rate in Haemostasis Diagnostics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
